Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and Kenvue Inc., the makers of Tylenol, for allegedly making false claims about the drug's potential link to autism. The lawsuit stems from debunked assertions made by Trump administration officials, including former Health and Human Services Secretary Robert F. Kennedy Jr.
Kennedy had claimed that taking Tylenol during pregnancy could increase a child's risk of developing autism. However, medical experts have repeatedly rejected these claims. The American College of Obstetricians and Gynecologists, along with other major medical organizations, have stated that acetaminophen is a safe pain reliever for pregnant women.
Studies have shown no evidence to support the claim that using Tylenol during pregnancy leads to developmental issues in children. Despite this, Kennedy had called anyone who takes the drug during pregnancy "irresponsible," and President Donald Trump announced that the FDA would notify physicians of a potential link between Tylenol and autism.
However, experts have dismissed these claims as misinformation. Johnson & Johnson has stated that it sold its consumer health business years ago, including Tylenol, to Kenvue Inc., which now holds all the rights and liability associated with the medication.
Kenvue has expressed concern over the perpetuation of misinformation about acetaminophen's safety and is committed to supporting scientific evidence. The company stands firm in its stance that these claims lack legal merit and scientific support, and it will continue to be successful in litigation.
Kennedy had claimed that taking Tylenol during pregnancy could increase a child's risk of developing autism. However, medical experts have repeatedly rejected these claims. The American College of Obstetricians and Gynecologists, along with other major medical organizations, have stated that acetaminophen is a safe pain reliever for pregnant women.
Studies have shown no evidence to support the claim that using Tylenol during pregnancy leads to developmental issues in children. Despite this, Kennedy had called anyone who takes the drug during pregnancy "irresponsible," and President Donald Trump announced that the FDA would notify physicians of a potential link between Tylenol and autism.
However, experts have dismissed these claims as misinformation. Johnson & Johnson has stated that it sold its consumer health business years ago, including Tylenol, to Kenvue Inc., which now holds all the rights and liability associated with the medication.
Kenvue has expressed concern over the perpetuation of misinformation about acetaminophen's safety and is committed to supporting scientific evidence. The company stands firm in its stance that these claims lack legal merit and scientific support, and it will continue to be successful in litigation.